Brentuximab vedotin + AVD in cHL: cost impact on adverse events, toxicity, second malignancies, end-of-life and subsequent lines of therapy in Italy
Article in AboutOpen (October 2023)
The most recent citing publications are shown below. View all 18 publications that cite this research output on Dimensions.
Article in AboutOpen (October 2023)
Article in Frontiers in Oncology (July 2023)
Article in Chinese Journal of Modern Nursing (June 2023)